Related Experiment Video
Updated: Jul 20, 2026

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
[Neurocognitive and psychosocial development in SGA and the indication for growth hormone therapy]
1Zentrum für Kinderheilkunde der Universität Bonn. m.noeker@uni-bonn.de
Insights
Growth hormone therapy (GHT) for small for gestational age (SGA) may improve neurocognitive and behavioral outcomes. Prognosis varies, with short stature-related issues responding best to GHT, while global issues may need psychological interventions.
Area of Science:
- Pediatric Endocrinology
- Developmental Psychology
- Neuroscience
Background:
- Small for gestational age (SGA) is associated with potential neurocognitive, behavioral, and educational impairments.
- Growth hormone therapy (GHT) is now indicated for SGA, raising expectations beyond growth improvement.
- Predicting individual developmental risks and GHT response in SGA remains challenging.
Purpose of the Study:
- To review neurocognitive and psychosocial outcomes in SGA.
- To present a framework for understanding developmental risks in SGA.
- To guide clinical differentiation between short stature-related and independent behavioral disorders.
Main Methods:
- Review of clinical and population-based studies on SGA neurocognitive and psychosocial outcomes.
- Delineation of an integrative framework for developmental risk in SGA.
- Analysis of factors influencing response to GHT.
Main Results:
- SGA is linked to diverse developmental risks, influenced by genetic, placental, and maternal factors.
- Short stature-related maladjustment responds best to GHT for psychosocial outcomes.
- Global developmental disturbances independent of short stature may require child psychology interventions.
Conclusions:
- Clinical differentiation is crucial for tailoring interventions in SGA.
- GHT effectiveness for psychosocial outcomes is highest in cases with specific short stature-related maladjustment.
- Child psychology interventions are vital for SGA individuals with global, short stature-independent disturbances.
Abstract:
After recent approval of treatment indication for growth hormone therapy (GHT) in SGA (small for gestational age) treatment expectations do not only refer to improvement of growth parameters but also to enhancement of suspected impairments of neurocognitive, behavioural and educational development. Clinical prognosis, however, is difficult which specific developmental risks are to be expected in the individual case and if their course may response to GHT. The paper reviews recent findings of clinical and population-based studies on neurocognitive and psychosocial outcome in SGA and delineates an integrative framework on the emergence and course of potential developmental risk comprising three major causes: Conclusions are drawn for the clinical differentiation of specific adaptation difficulties towards short stature versus global, short stature independent behavioral disorders. Psychosocial outcome parameters can be expected to respond best to endocrinological growth stimulation in conditions with a high specific short stature related maladjustment; in turn, the relevance of child psychology interventions increases in conditions with global disturbance and short stature independent origin.
Related Concept Videos
Nature and Nurture
Hypoglycemia and Glucagon
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Psychological and Sociocultural Causes of Schizophrenia
Introduction to Developmental Psychology
Pharmacodynamics in Geriatric Patients: Effects of Age
